https://www.selleckchem.com/pr....oducts/rxdx-106-cep-
Hyperlipasemia is frequent in critically ill people without evidence of acute pancreatitis (AP), and has been associated with increased morbidity and mortality. To evaluate the prevalence of hyperlipasemia at admission and development of hyperlipasemia during hospitalization in critically ill dogs, explore factors associated with hyperlipasemia, and evaluate association with outcome. Critically ill, client owned dogs (n = 136, presented on emergency and admitted to the intensive care unit, that had 1,2-o-dilauryl-rac-glycer
Like
Comment
Share
